Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.422
+0.022 (0.49%)
At close: May 15, 2025, 4:00 PM
4.550
+0.128 (2.90%)
After-hours: May 15, 2025, 4:01 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $2.58 million as of May 15, 2025. Its market cap has decreased by -79.94% in one year.
Market Cap
2.58M
Enterprise Value
1.93M
1-Year Change
-79.94%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $2.58M, a decrease of -99.20%. That is a compound annual growth rate of -75.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 2.57M | -72.53% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.87B |
| Johnson & Johnson | 359.13B |
| AbbVie | 333.71B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 280.84B |
| Abbott Laboratories | 225.20B |
| Novartis AG | 213.30B |
| AstraZeneca | 209.59B |